Annual Drug Patent Expirations for ZEPZELCA
Zepzelca is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has twenty-nine patent family members in twenty-three countries.
The generic ingredient in ZEPZELCA is lurbinectedin. One supplier is listed for this compound. Additional details are available on the lurbinectedin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
